Enregistrement - Lobbyistes salariés d'entreprises

Objets

• Commerce international
• Industrie
• Propriété intellectuelle
• Recherche et développement
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• Canadian Agency for Drugs and Technologies in Health (CADTH), including Therapeutic Reviews and the Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.
• Federal Innovation agenda. Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to ensure that innovative medicines, and our contribution to Research and Development in Canada are part of the consultation process in the development of this new innovation agenda.
• Federal Public Drug Plans, with respect to the reimbursement of drug products for the Federal plan beneficiaries
• NAFTA - Working with our Industry Associations, the renewal of the North American Free Trade Agreement, and impact on Intellectual Property
• Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada.
• Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to provide industry recommendations to the Advisory Council on the implementation of Pharmacare which was announced in Budget 2018

Politique ou Programme, Règlement

• R&D requirements set forth through the Patent Medicines Pricing Review Board (PMPRB)
• Subsequent Entry Biologics (SEBs)/ Biosimilars: information regarding approval framework supported and protected by Regulations in harmonization with approaches taken by the European Union or the U.S. for instance.

Règlement

• Patented Medicine Prices Review Board (PMPRB) Regulations as related to reporting requirements and pricing guidelines.
• Patented Medicines (Notice of Compliance) Regulations as it relates to regulation of intellectual property for therapeutic products. Novartis is working with our industry associations (Innovative Medicines Canada and BIOTECanada) to provide a written response to Guideline consultation process and will also provide our own corporate submission.
• Proposed Regulation Changes to the Patent Medicines Pricing Review Board

Techniques de communication

• Communication écrite
• Communication orale

Institutions gouvernementales

• Affaires mondiales Canada (AMC)
• Agence de promotion économique du Canada atlantique (APECA)
• Anciens Combattants Canada (ACC)
• Cabinet du Premier ministre (CPM)
• Chambre des communes
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Finances Canada (FIN)
• Innovation, Sciences et Développement économique Canada (ISDE)
• Santé Canada (SC)
• Secrétariat du Conseil du Trésor du Canada (SCT)

Adresse :
385 Bouchard Blvd.
Dorval, QC  H9S 1A9
Canada

Numéro de téléphone : 514-631-6775

Renseignements sur la société mère